BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20940404)

  • 1. Transforming properties of 8p11-12 amplified genes in human breast cancer.
    Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
    Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.
    Mahmood SF; Gruel N; Nicolle R; Chapeaublanc E; Delattre O; Radvanyi F; Bernard-Pierrot I
    Am J Pathol; 2013 Nov; 183(5):1634-1644. PubMed ID: 24051013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
    Bernard-Pierrot I; Gruel N; Stransky N; Vincent-Salomon A; Reyal F; Raynal V; Vallot C; Pierron G; Radvanyi F; Delattre O
    Cancer Res; 2008 Sep; 68(17):7165-75. PubMed ID: 18757432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.
    Streicher KL; Yang ZQ; Draghici S; Ethier SP
    Oncogene; 2007 Mar; 26(14):2104-14. PubMed ID: 17001308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
    Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
    Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.
    Yang ZQ; Streicher KL; Ray ME; Abrams J; Ethier SP
    Cancer Res; 2006 Dec; 66(24):11632-43. PubMed ID: 17178857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
    Ray ME; Yang ZQ; Albertson D; Kleer CG; Washburn JG; Macoska JA; Ethier SP
    Cancer Res; 2004 Jan; 64(1):40-7. PubMed ID: 14729606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive profiling of 8p11-12 amplification in breast cancer.
    Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
    Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
    Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
    Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
    Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
    Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
    Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
    Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
    Kang D; Cho HS; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Hayami S; Tsunoda T; Field HI; Matsuda K; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Genes Chromosomes Cancer; 2013 Feb; 52(2):126-39. PubMed ID: 23011637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of 8p11.23 in cancers and the role of amplicon genes.
    Voutsadakis IA
    Life Sci; 2021 Jan; 264():118729. PubMed ID: 33166592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
    Martinez-Garcia E; Popovic R; Min DJ; Sweet SM; Thomas PM; Zamdborg L; Heffner A; Will C; Lamy L; Staudt LM; Levens DL; Kelleher NL; Licht JD
    Blood; 2011 Jan; 117(1):211-20. PubMed ID: 20974671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon.
    Still IH; Hamilton M; Vince P; Wolfman A; Cowell JK
    Oncogene; 1999 Jul; 18(27):4032-8. PubMed ID: 10435627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.
    Luo J; Liu S; Leung S; Gru AA; Tao Y; Hoog J; Ho J; Davies SR; Allred DC; Salavaggione AL; Snider J; Mardis ER; Nielsen TO; Ellis MJ
    J Mol Diagn; 2017 Jan; 19(1):147-161. PubMed ID: 27993329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
    Yang ZQ; Albertson D; Ethier SP
    Cancer Genet Cytogenet; 2004 Nov; 155(1):57-62. PubMed ID: 15527903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
    Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
    Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
    Jiang Y; Liu L; Shan W; Yang ZQ
    Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer.
    Rutkovsky AC; Yeh ES; Guest ST; Findlay VJ; Muise-Helmericks RC; Armeson K; Ethier SP
    BMC Cancer; 2019 May; 19(1):491. PubMed ID: 31122207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.